What primary treatment option is used in patients with chronic obstructive pulmonary disease?

The primary treatment option for patients with chronic obstructive pulmonary disease (COPD) is bronchodilators. These medications work by relaxing the muscles of the airways, allowing them to open wider and making it easier for patients to breathe. Bronchodilators come in two main types: short-acting, which provide quick relief during flare-ups, and long-acting, which are used for ongoing control of symptoms.

The goal in managing COPD is to relieve symptoms and improve the overall functioning and quality of life for the patient. While inhaled corticosteroids can be beneficial in certain cases, particularly in individuals with significant asthma components or frequent exacerbations, bronchodilators are the cornerstone of therapy for almost all patients with COPD.

Systemic steroids can be used during acute exacerbations but are not recommended for routine management due to their potential side effects. Antibiotics may be prescribed if there is a bacterial infection but are not a primary treatment for the chronic condition itself. Therefore, the use of bronchodilators is essential in the long-term management plan for COPD.